Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...

Accurate information and leadership buy-in are essential. The researchers noted three types of resistance that are common are denying, defending and distancing. One of the strategies suggested by ...

Panelists discuss how overcoming resistance to EGFR TKIs requires next-generation inhibitors and more individualized treatment strategies. Panelists discuss how resistance to EGFR tyrosine kinase ...

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

In recent years, we’ve seen tremendous growth in diversity, equity, and inclusion initiatives. Many people have eagerly embraced these efforts, but some have criticized and resisted them, including ...

Two companion studies published in Cancer Research from scientists at Moffitt Cancer Center identify distinct but complementary approaches to overcoming drug resistance in KRAS G12C–mutant non-small ...

It’s the foundation for overcoming resistance, and it’s a vital skill I now teach to leaders in healthcare, education, and beyond. Here are the steps I took—and that you can take—to navigate ...

Resistance—the pushback we feel when facing change—isn’t a flaw; it’s data. It signals unmet needs, unprocessed fears, or a lack of clarity. Why do we hesitate, avoid, or resist what’s ahead? With ...